Efficacy and safety of 1% clascoterone cream through 12 weeks in patients ≥12 years of age with facial acne vulgaris

被引：0
|
作者：
Cartwright, Martina [1 ]
Moro, Luigi [2 ]
Fragasso, Enrico [2 ]
机构：
[1] Cassiopea Inc, San Diego, CA USA
[2] Cassiopea SpA, Lainate, Italy
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34781
引用
收藏
页码：AB49 / AB49
页数：1
相关论文
共 50 条
  • [21] A Novel Gel Formulation of 0.25% Tretinoin and 1.2% Clindamycin Phosphate: Efficacy in Acne Vulgaris Patients Aged 12 to 18 Years
    Eichenfield, Lawrence F.
    Wortzman, Mitchell
    PEDIATRIC DERMATOLOGY, 2009, 26 (03) : 257 - 261
  • [22] The safety and efficacy of ERCP in the pediatric patients up to 12 years of age with standard duodenoscope by adult gastroenterologists
    M. Salih
    H. Z. Malik
    Y. Abbas
    N. J. Shah
    Journal of Pediatric Endoscopic Surgery, 2022, 4 (3) : 117 - 122
  • [23] Efficacy and safety of alogliptin monotherapy over 12 weeks in patients with type 2 diabetes
    Fleck, Penny
    Christopher, Ronald
    Covington, Paul
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A143 - A143
  • [24] Efficacy and Safety of Topical Flutamide 1% Gel as an Adjunctive Therapy in the Treatment of Patients With Acne Vulgaris
    Nassar, Amany
    El Sayed, Ayman
    Samy, Afnan
    Essam, Reham
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2023, 27 (05) : 472 - 475
  • [25] Evaluation of serum levels of interleukins 1-beta, 10 and 12 in patients with acne vulgaris
    Mohamed, Marwa
    Shehata, Hanan Abdel Aaty
    Fahmy, Nahed Fathallah
    Saleh, Ramadan
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (12) : 7100 - 7106
  • [26] The efficacy and safety of inhaled zanamivir in the treatment of influenza A and B in pediatric patients 5-12 years of age
    Hedrick, JA
    Barzilai, A
    Behre, U
    Henderson, FW
    Hammond, JM
    Flack, NP
    Keene, O
    PEDIATRIC RESEARCH, 2000, 47 (04) : 265A - 265A
  • [27] Efficacy and safety of 8-or 12 weeks of glecaprevir/pibrentasvir in patients with signs of portal hypertension
    Brown, Robert
    Collins, Michelle
    Emmett, Amanda
    Topp, Andrew
    Burroughs, Margaret
    Ferreira, Rosa
    Feld, Jordan
    JOURNAL OF HEPATOLOGY, 2021, 75 : S794 - S794
  • [28] Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension
    Robert S. Brown
    Michelle A. Collins
    Simone I. Strasser
    Amanda Emmett
    Andrew S. Topp
    Margaret Burroughs
    Rosa Ferreira
    Jordan J. Feld
    Infectious Diseases and Therapy, 2022, 11 : 913 - 924
  • [29] Efficacy and Safety of 8-or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension
    Brown, Robert S., Jr.
    Collins, Michelle A.
    Strasser, Simone, I
    Emmett, Amanda
    Topp, Andrew S.
    Burroughs, Margaret
    Ferreira, Rosa
    Feld, Jordan J.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 913 - 924
  • [30] Treatment of 2,453 Acne Vulgaris Patients Aged 12-17 Years With the Fixed-dose Adapalene-benzoyl Peroxide Combination Topical Gel: Efficacy and Safety
    Eichenfield, Lawrence F.
    Jorizzo, Joseph L.
    Dirschka, Thomas
    Taub, Amy Forman
    Lynde, Charles
    Graeber, Michael
    Kerrouche, Nabil
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (11) : 1395 - 1401
12345